Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Mario, Velussi"'
Autor:
Giovanni Cioffi, Valeria Manicardi, D Girfoglio, Paolo Verdecchia, Pompilio Faggiano, Serge Masson, Marco Comaschi, Mario Velussi, Andrea Di Lenarda, Augusto Travaglini, Aldo P. Maggioni, Donata Lucci, Carlo Giorda
Publikováno v:
Diabetes Research and Clinical Practice. 101:236-242
Aims Left ventricular dysfunction (LVD) in type 2 diabetes mellitus (DM) (DYDA) study is a prospective investigation enrolling 960 with DM without overt cardiac disease. At baseline, a high prevalence of LVD was detected by analysing midwall shorteni
Autor:
Pompilio Faggiano, Giovanni Cioffi, Luigi Tarantini, Andrea Di Lenarda, Giovanni de Simone, Marcello Chinali, Gian Francesco Mureddu, Donata Lucci, Serge Masson, Roberto Latini, Paolo Verdecchia, Mario Velussi, Carlo Giorda, Marco Comaschi
Publikováno v:
Journal of Hypertension. 29:1994-2003
An inappropriately high left ventricular mass (iLVM) may be detected in patients with diabetes mellitus. Several hemodynamic and nonhemodynamic factors stimulating LVM growth may actively operate in these patients. In this study, we assessed prevalen
Autor:
Giovanni, Cioffi, Carlo B, Giorda, Marcello, Chinali, Andrea, Di Lenarda, Pompilio, Faggiano, Donata, Lucci, Aldo P, Maggioni, Serge, Masson, Gian Francesco, Mureddu, Luigi, Tarantini, Mario, Velussi, Marco, Comaschi, B, Pinamonti
Publikováno v:
European Journal of Preventive Cardiology. 19:935-943
Individuals with diabetes mellitus (DM) have a higher risk to develop heart failure. Clinical guidelines emphasize the importance of early diagnosis of left ventricular dysfunction (LVD) and preventive interventions in these patients. In this study w
Autor:
Carlo B, Giorda, Giovanni, Cioffi, Giovanni, de Simone, Andrea, Di Lenarda, Pompilio, Faggiano, Roberto, Latini, Donata, Lucci, Aldo P, Maggioni, Luigi, Tarantini, Mario, Velussi, Paolo, Verdecchia, Marco, Comaschi, B, Pinamonti
Publikováno v:
European Journal of Cardiovascular Prevention & Rehabilitation. 18:415-423
Better knowledge of prevalence and early-stage determinants of subclinical left ventricular dysfunction (LVD) in type 2 diabetes would be useful to design prevention strategies. The objective of the LVD in Diabetes (DYDA) study was to assess these po
Autor:
Angelo Avogaro, Edoardo Mannucci, Marina Maggini, Mario Velussi, Ele Ferrannini, Stefania Spila Alegiani, Salvatore Turco, Carlo Giorda, Roberto Raschetti, Flavia Lombardo
Publikováno v:
Diabetes Care
OBJECTIVE—The purpose of this study was to assess incidence of and risk factors for recurrent cardiovascular disease (CVD) in type 2 diabetes. RESEARCH DESIGN AND METHODS—We estimated the incidence of recurrent cardiovascular events in type 2 dia
Autor:
Carlo Giorda, Salvatore Turco, Edoardo Mannucci, Roberto Raschetti, Stefania Spila-Alegiani, Angelo Avogaro, Flavia Lombardo, Ele Ferrannini, Marina Maggini, Mario Velussi
Publikováno v:
Diabetes Care. 30:1241-1247
OBJECTIVE—Cardiovascular disease (CVD) is the main cause of morbidity/mortality in diabetes. We set forth to determine incidence and identify predictors (including microvascular complications and treatment) of first coronary heart disease (CHD) eve
Autor:
Roberta Zucchetti, Carlo Giorda, Guglielmo Armienti, Gerardo Medea, Angelo Avogaro, Pietro Guida, Marco Comaschi, Edoardo Mannucci, Mario Velussi
Publikováno v:
Nutrition, Metabolism and Cardiovascular Diseases. 17:32-40
Background and aims The greatest decrease in mortality from cardiovascular disease (CAD) that can be achieved with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) is seen in patients with the highest risk for CAD, such as diabeti
Autor:
Antonio Ceriello, Carlo Schweiger, Elena Biagini, Mario Velussi, Massimo Cafiero, Paolo Bellis, Claudio Rapezzi, Robin M. T. Cooke
Publikováno v:
Journal of cardiovascular medicine (Hagerstown, Md.). 9(9)
OBJECTIVES To evaluate implementation of low-density lipoprotein cholesterol (LDL-C) control recommendations in secondary care and explore key points in the decisional workup. METHODS AND RESULTS In a nationwide survey of secondary-care outpatients (
Autor:
Ele Ferrannini, Carlo Giorda, Salvatore Turco, Flavia Lombardo, Roberto Raschetti, Stefania Spila Alegiani, Edoardo Mannucci, Angelo Avogaro, Marina Maggini, Mario Velussi
Publikováno v:
Stroke. 38(4)
Background and Purpose— Type 2 diabetes mellitus is a strong predictor of cerebrovascular disease, yet few studies have assessed the incidence of stroke and the role of other risk factors in unselected type 2 diabetes mellitus populations. Methods
Autor:
Renato Urso, Marco Comaschi, Aldo P. Maggioni, Giovanni Cioffi, Donata Lucci, Mario Velussi, Luigi Tarantini, Gian Francesco Mureddu, Pompilio Faggiano, Carlo Giorda, Tarcisio Vago, D Girfoglio, Serge Masson, Roberto Latini
Publikováno v:
Diabetes Care
Although diabetes is a major risk factor for ischemic heart disease or heart failure (HF), and despite the fact that echocardiography has revealed a high prevalence of left ventricular (LV) diastolic and systolic dysfunctions and hypertrophy (1–3),